ASH Logo

Ashland Inc. (ASH) 

NYSE$51.82
Market Cap
$2.45B
Sector
Basic Materials
Industry
Chemicals—Specialty
Rank in Sector
6 of 145
Rank in Industry
2 of 50

ASH Insider Trading Activity

ASH Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$2,211,927
2
33
Sells
$597,262
4
67

Related Transactions

NOVO GUILLERMOChair of the Board and CEO
1
$2.01M
0
$0
$2.01M
Assis Alessandra FaccinSVP and GM, Life Sciences
1
$201,600
0
$0
$201,600
BONI ERIC NVP, Finance & Prinpl Acctg Off
0
$0
1
$35,210
$-35,210
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.
0
$0
2
$79,855
$-79,855
WILLIS J KEVINSVP and CFO
0
$0
1
$482,198
$-482,198

About Ashland Inc.

Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and â€¦

Insider Activity of Ashland Inc.

Over the last 12 months, insiders at Ashland Inc. have bought $2.21M and sold $597,262 worth of Ashland Inc. stock.

On average, over the past 5 years, insiders at Ashland Inc. have bought $19.01M and sold $59.46M worth of stock each year.

Highest buying activity among insiders over the last 12 months: NOVO GUILLERMO (Chair of the Board and CEO) — $2.01M. Assis Alessandra Faccin (SVP and GM, Life Sciences) — $201,600.

The last purchase of 3,150 shares for transaction amount of $201,600 was made by Assis Alessandra Faccin (SVP and GM, Life Sciences) on 2025‑01‑31.

List of Insider Buy and Sell Transactions, Ashland Inc.

2025-01-31PurchaseNOVO GUILLERMOChair of the Board and CEO
31,294
0.0668%
$64.24
$2.01M
-8.32%
2025-01-31PurchaseAssis Alessandra FaccinSVP and GM, Life Sciences
3,150
0.0067%
$64.00
$201,600
-8.32%
2024-12-05SaleBONI ERIC NVP, Finance & Prinpl Acctg Off
451
0.001%
$78.07
$35,210
-16.06%
2024-11-19SaleLAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.
162
0.0003%
$75.54
$12,237
-14.67%
2024-11-15SaleLAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.
868
0.0018%
$77.90
$67,617
-15.19%
2024-09-04SaleWILLIS J KEVINSVP and CFO
5,487
0.0112%
$87.88
$482,198
-18.00%
2024-02-16SaleLAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.
844
0.0017%
$92.54
$78,104
-3.29%
2023-12-07SaleBONI ERIC NPrincipal Accounting Officer
843
0.0016%
$82.38
$69,446
+8.84%
2023-09-05SaleWILLIS J KEVINSr.VP &Chief Financial Officer
7,866
0.0155%
$86.54
$680,724
+7.00%
2022-09-01SaleSandler Ricky CSee Remarks
224,156
0.415%
$100.20
$22.46M
-0.46%
2022-09-01SaleEMINENCE CAPITAL, LP
224,156
0.415%
$100.20
$22.46M
-0.46%
2022-09-01PurchaseSandler Ricky CSee Remarks
224,156
0.415%
$100.20
$22.46M
-0.46%
2022-09-01PurchaseEMINENCE CAPITAL, LP
224,156
0.415%
$100.20
$22.46M
-0.46%
2022-06-08SaleBONI ERIC NPrincipal Accounting Officer
2,657
0.0049%
$109.50
$290,942
-5.30%
2022-06-07SaleBONI ERIC NPrincipal Accounting Officer
2,657
0.0049%
$109.50
$290,942
-6.83%
2022-06-02SaleWILLIS J KEVINSr.VP &Chief Financial Officer
4,235
0.0077%
$105.58
$447,131
-4.36%
2022-06-01SaleWILLIS J KEVINSr.VP &Chief Financial Officer
2,374
0.0044%
$105.58
$250,647
-2.08%
2022-05-17PurchaseSandler Ricky CSee Remarks
48,800
0.0901%
$101.27
$4.94M
+2.28%
2022-05-17PurchaseEMINENCE CAPITAL, LP
48,800
0.0901%
$101.27
$4.94M
+2.28%
2021-09-10SaleWILLIS J KEVINChief Financial Officer
2,208
0.0039%
$94.30
$208,214
+8.89%
Total: 66
*Gray background shows transactions not older than one year

Insider Historical Profitability

2.19%
NOVO GUILLERMOChair of the Board and CEO
31294
0.0663%
$1.62M20
<0.0001%
Assis Alessandra FaccinSVP and GM, Life Sciences
3150
0.0067%
$163,233.0010
EMINENCE CAPITAL, LP
4083978
8.6556%
$211.63M21
+0.91%
Sandler Ricky CSee Remarks
4083978
8.6556%
$211.63M22
+0.91%
KALYANA SWAMINATHAN ASHOKSr VP & Gen Mgr, Life Sciences
100
0.0002%
$5,182.0010
+14.77%
*Gray background shows insiders who have made transactions during last year

ASH Institutional Investors: Active Positions

Increased Positions180+42.76%5M+10.4%
Decreased Positions182-43.23%4M-9.79%
New Positions55New1MNew
Sold Out Positions59Sold Out1MSold Out
Total Postitions419-0.48%45M+0.61%

ASH Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$248,812.0010.49%4.93M+66,530+1.37%2024-12-31
Blackrock, Inc.$242,817.0010.23%4.81M+325,623+7.26%2024-12-31
Eminence Capital, Lp$144,397.006.09%2.86M+212,916+8.04%2024-12-31
Dimensional Fund Advisors Lp$142,288.006%2.82M+44,018+1.59%2024-12-31
Massachusetts Financial Services Co /Ma/$141,693.005.97%2.81M+208,320+8.02%2024-12-31
Allspring Global Investments Holdings, Llc$86,897.003.66%1.72M-16,321-0.94%2024-12-31
Diamond Hill Capital Management Inc$79,143.003.34%1.57M-358,191-18.6%2024-12-31
State Street Corp$78,838.003.32%1.56M+46,196+3.05%2024-12-31
Omega Advisors Inc.$73,371.003.09%1.45M+363,465+33.34%2024-12-31
Clearbridge Investments, Llc$71,047.003%1.41M-257,637-15.47%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.